Systematic Pan-cancer Functional Inference and Validation of Hyper, Hypo and Neomorphic Mutations
Tagore, S.; Tsang, S.; Mills, G. B.; Califano, A.
Show abstract
While the functional effects of many recurrent cancer mutations have been characterized, the TCGA repository comprises more than 10M non-recurrent events, whose function is unknown. We propose that the context specific activity of transcription factor (TF) proteins--as measured by expression of their transcriptional targets--provides a sensitive and accurate reporter assay to assess the functional role of oncoprotein mutations. Analysis of differentially active TFs in samples harboring mutations of unknown significance--compared to established gain (GOF/hypermorph) or loss (LOF/hypomorph) of function--helped functionally characterize 577,866 individual mutational events across TCGA cohorts, including identification of mutations that are either neomorphic (gain of novel function) or phenocopy other mutations (mutational mimicry). Validation using mutation knock-in assays confirmed 15 out of 15 predicted gain and loss of function mutations and 15 of 20 predicted neomorphic mutations. This could help determine targeted therapy in patients with mutations of unknown significance in established oncoproteins.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics 95%
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 95%
- A single-cell based precision medicine approach using glioblastoma patient-specific models 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.